Açık Akademik Arşiv Sistemi

XELOX plus bevacizumab vs. FOLFIRI plus bevacizumab treatment for first-line chemotherapy in metastatic colon cancer: a retrospective study of the Anatolian Society of Medical Oncology

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)